Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPC

NCT02864784 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Budget

Conditions

Castrate Resistant Prostate Cancer With Bone Metastasis

Interventions

DRUG: Amorphous calcium carbonate
OTHER: Placebo

Sponsor

Amorphical Ltd.